# Episode 164 - Natalia Misciattelli - CEO of AAVantgarde

Page: https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-164-natalia-misciattelli-ceo-of-aavantgarde
Text version: https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-164-natalia-misciattelli-ceo-of-aavantgarde.md
Podcast: [The BioHub - by Avetix](https://stenobird.com/podcast/the-biohub-by-avetix-7252289)
Published: 2026-04-29T08:14:30+00:00
Episode link: https://podcasters.spotify.com/pod/show/max-brennan4/episodes/Episode-164---Natalia-Misciattelli---CEO-of-AAVantgarde-e3iklu2
Audio file: https://anchor.fm/s/f0076084/podcast/play/119215490/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-3-29%2F423101640-44100-2-e7f859e7459b4.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-164-natalia-misciattelli-ceo-of-aavantgarde
Duration seconds: 1076

## Resource

On this episode we discuss the AAVantgarde story with CEO, Natalia Misciatelli. Founded by Professor Alberto Auricchio in 2021 as a spin-out from Telethon Institute of Genetics and Medicine in Naples, we discuss their dual-vector and intein-based platforms and how the team are positioning to deliver large therapeutic genes for inherited retinal diseases. Backed by household VC names including; Forbion, Atlas Venture, & Sofinnova, Natalia and the team are pursuing game-changing prospects for Stargardt & Usher1b patients. Check this episode out to hear more about their programs, particularly ahead of ARVO where the team will share data from their LUCE ph1/2 study in Usher1b.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-164-natalia-misciattelli-ceo-of-aavantgarde/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-164-natalia-misciattelli-ceo-of-aavantgarde.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.